LADENBURG THALMANN FINANCIAL SERVICES INC. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2019$45,000
+150.0%
5,168
+209.3%
0.00%
Q3 2019$18,000
-5.3%
1,671
+13.5%
0.00%
Q2 2019$19,000
-77.6%
1,472
-32.1%
0.00%
-100.0%
Q1 2019$85,000
+608.3%
2,169
+253.8%
0.00%
Q4 2018$12,000
-62.5%
613
-11.3%
0.00%
Q3 2018$32,000
-69.5%
691
-55.3%
0.00%
-100.0%
Q2 2018$105,0000.0%1,5470.0%0.00%0.0%
Q1 2018$105,000
+176.3%
1,547
+307.1%
0.00%
Q4 2017$38,000
-15.6%
380
+1.6%
0.00%
Q3 2017$45,000
+36.4%
3740.0%0.00%
Q2 2017$33,000
+135.7%
3740.0%0.00%
Q1 2017$14,000
+27.3%
3740.0%0.00%
Q4 2016$11,000
+120.0%
374
+405.4%
0.00%
Q3 2016$5,000
+150.0%
740.0%0.00%
Q2 2016$2,0000.0%740.0%0.00%
Q1 2016$2,000
-91.3%
74
-75.3%
0.00%
Q4 2015$23,000
-57.4%
299
-57.8%
0.00%
-100.0%
Q3 2015$54,000
-29.9%
709
+7.6%
0.00%0.0%
Q2 2015$77,000
-53.9%
659
-6.9%
0.00%
-66.7%
Q1 2015$167,000
+26.5%
708
+1.3%
0.00%0.0%
Q4 2014$132,000
-42.1%
699
-26.9%
0.00%
-50.0%
Q3 2014$228,000
+5600.0%
956
+1670.4%
0.01%
Q2 2014$4,000
+300.0%
54
+671.4%
0.00%
Q1 2014$1,00070.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
HARVARD MANAGEMENT CO INC 600,000$45,216,0003.56%
Avalon Global Asset Management LLC 32,900$2,479,0001.79%
CORNERSTONE CAPITAL MANAGEMENT LLC 495,145$37,314,0001.58%
BB BIOTECH AG 521,991$39,337,0001.25%
WEATHERBIE CAPITAL, LLC 137,041$10,327,0001.20%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$428,527,0001.19%
TOBAM 318,384$23,994,0000.94%
Orbimed Advisors 1,195,500$90,093,0000.91%
Capital International Sarl 109,405$8,245,0000.74%
CAPITAL INTERNATIONAL LTD /CA/ 145,697$10,980,0000.73%
View complete list of PUMA BIOTECHNOLOGY INC shareholders